Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Island Pharmaceuticals receives third patent for dengue fever drug
    • News

    Island Pharmaceuticals receives third patent for dengue fever drug

    Sorry COVID, there’s a slew of other diseases that require our attention as well. One of which is the highly contagious dengue fever. Joy. Transmitted by mosquitoes, dengue infects an estimated 390 million people each year. That number is set to rise as global warming sees mosquitoes travelling further than ever before. Treatment for those

    Read More
    Public
  • How to find the winners in the mining services sector
    • Opinion

    How to find the winners in the mining services sector

    At a time of bumper dividend payouts from the likes of Rio Tinto and – presumably – BHP, most investors seeking a resources exposure would be happy to invest directly in the major producers. Of course, the history of resources is also about endless boom-and-bust cycles – and if history doesn’t repeat it sure will

    Read More
    Public
  • Father of four pleads with boss to return to office
    • Satire

    Father of four pleads with boss to return to office

    For many Australian parents, pandemic-enforced lockdowns in Melbourne and Sydney have been a blessing in disguise by giving them more special time at home with their families. Hugh Honey is not one of those parents. Working from home in his three bedroom townhouse with twin daughters aged 15 and twin sons aged 12 that are

    Read More
    Public
  • Exceeding revenue guidance, total Class platform users increase 123%
    • News

    Exceeding revenue guidance, total Class platform users increase 123%

    Less than 12 months since launching their latest product with a first mover advantage, wealth management software company Class Limited (ASX: CL1) has reported a 25% increase in revenue having delivered a product that the wealth administration industry had been screaming out for.  Long-time leaders in the superannuation sector courtesy of their Class SMSF software,

    Read More
    Public
  • More clinic acquisitions sees Healthia’s allied health portfolio grow 109%
    • News

    More clinic acquisitions sees Healthia’s allied health portfolio grow 109%

    109% portfolio growth over three years is the stuff of dreams for professional investors but for healthcare company Healthia (ASX: HLA) it’s a reality, with the nationwide operator’s latest acquisition taking their total allied health businesses to 217. Those 217 businesses which span podiatry, physiotherapy, optometry, audiology, retail and manufacturing is more than double the

    Read More
    Public
  • This ‘proptech’ is transforming the way we buy and sell homes
    • News

    This ‘proptech’ is transforming the way we buy and sell homes

    Almost every industry has been forced to pivot and adapt to the increasingly digital world in the wake of COVID-19. Self proclaimed ‘proptech’, Openn Negotiation (ASX: OPN) offers a platform for the real estate industry to operate online. The Openn cloud-based software platform supports real estate agents to sell properties by facilitating negotiation, contracting and

    Read More
    Public
  • «
  • ‹
  • 470
  • 471
  • 472
  • 473
  • 474
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.